Conversion to sirolimus

MeSH terms

• Adrenal Cortex Hormones / adverse effects
• Adrenal Cortex Hormones / therapeutic use
• Calcineurin Inhibitors
• Clinical Trials as Topic
• Diabetes Mellitus, Type 2 / chemically induced
• Diabetes Mellitus, Type 2 / epidemiology
• Diabetes Mellitus, Type 2 / prevention & control
• Disease Susceptibility
• Drug Administration Schedule
• Hemolytic-Uremic Syndrome / chemically induced
• Hemolytic-Uremic Syndrome / prevention & control
• Humans
• Hypertension / etiology
• Hypertension / prevention & control
• Immunocompromised Host
• Immunosuppressive Agents / administration & dosage
• Immunosuppressive Agents / adverse effects
• Immunosuppressive Agents / therapeutic use*
• Incidence
• Kidney Diseases / chemically induced
• Kidney Diseases / prevention & control
• Kidney Transplantation*
• Mycophenolic Acid / administration & dosage
• Mycophenolic Acid / analogs & derivatives
• Mycophenolic Acid / therapeutic use
• Neoplasms / epidemiology
• Neoplasms / etiology
• Neoplasms / prevention & control
• Postoperative Complications / chemically induced
• Postoperative Complications / epidemiology
• Postoperative Complications / etiology
• Postoperative Complications / prevention & control
• Sirolimus / administration & dosage
• Sirolimus / adverse effects
• Sirolimus / therapeutic use*